Causal association of serum biomarkers with oral cavity and oropharyngeal cancer : a mendelian randomization study

© 2023. The Author(s)..

BACKGROUND: Observational epidemiological studies revealed that multiple serum biomarkers can be associated with the risk of oral and oropharyngeal cancer (OC/OPC). However, the causal relationship between them remains largely unknown. This study aimed to investigate the causal relationship between potential serum biomarkers and (OC/OPC).

METHODS: A two-sample Mendelian randomization (MR) approach was performed to assess the causal association of 10 serum biomarkers with the risk of OC / OPC. Summary data on OC/OPC were obtained from a GWAS meta-analysis that included 2497 cases and 2928 controls. The TwoSampleMR package in R was used to perform MR analyzes. Inverse-variance weighted (IVW), Weighted median and MR-Egger methods were used to assess causal effects.

RESULTS: Suggestive associations with increased risk of C-reactive protein (CRP) (OR 1.52, 95% CI 1.14 to 2.02), using the IVW method. MR-Egger regression suggested that directional pleiotropy was unlikely to bias the result (P = 0.19). The findings were robust to sensitivity analyzes. The risk of OC/OPC was not associated with serum 25-hydroxyvitamin D, HDL cholesterol, LDL cholesterol, total cholesterol, triglycerides, adiponectin, leptin, HbA1C and Insulin-like growth factor 1 (IGF 1).

CONCLUSIONS: This study supports that CRP was causally associated with an increased risk of oral and oropharyngeal cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

BMC oral health - 23(2023), 1 vom: 09. Dez., Seite 987

Sprache:

Englisch

Beteiligte Personen:

Liu, Weixing [VerfasserIn]
Liu, Yue [VerfasserIn]
Li, Pei [VerfasserIn]
Wang, Zhiyuan [VerfasserIn]
Chen, Jia [VerfasserIn]
Liu, Hui [VerfasserIn]
Ye, Jin [VerfasserIn]

Links:

Volltext

Themen:

9007-41-4
Biomarkers
C-Reactive Protein
C-reactive protein
Cholesterol, HDL
Journal Article
Mendelian randomization
Meta-Analysis
Oral cancer
Oropharyngeal cancer
Research Support, Non-U.S. Gov't
Serum biomarkers

Anmerkungen:

Date Completed 16.12.2023

Date Revised 12.01.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s12903-023-03729-x

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365621188